Diana Landa

Diana Landa has a solid work experience spanning over several companies. Diana is currently the Vice President of Regulatory Affairs at Sutro Biopharma, Inc., a position they have held since November 2020. Prior to that, Diana worked at Amgen for seven years. Diana held the position of Executive Director of Global Regulatory Affairs from October 2018 to November 2020, and before that, they were the Director of Global Regulatory Affairs from February 2013 to October 2018. Before joining Amgen, Diana worked at Teva Pharmaceuticals for ten years, starting as a Manager of Regulatory Affairs in March 2000 and progressing to become the Director of Global Regulatory Affairs Innovative R&D from October 2010 to February 2013. Their responsibilities at Teva included developing and executing global regulatory strategies for a portfolio of innovative biologic products, leading cross-functional teams, and managing interactions with health authorities. Diana's career began at DuPont, where they worked as a Senior Laboratory Technician from June 1998 to March 2000.

Diana Landa completed their Bachelor of Arts (BA) degree in Chemistry, Biochemistry at La Salle University from 1994 to 1998. Later, they pursued their Master of Science (M.S.) degree in Regulatory Affairs/Quality Assurance at Temple University. However, specific dates or duration for this degree are not provided.